Stock analysts at StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a research note issued to investors on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Price Performance
NASDAQ CALA opened at $0.01 on Wednesday. The stock’s fifty day moving average is $0.02 and its two-hundred day moving average is $0.02. Calithera Biosciences has a fifty-two week low of $0.01 and a fifty-two week high of $0.13.
About Calithera Biosciences
Featured Articles
- Five stocks we like better than Calithera Biosciences
- There Are Different Types of Stock To Invest In
- RXO Shares Surge Following New Acquisition Deal
- Market Cap Calculator: How to Calculate Market Cap
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
